Atlas Trials

Chembrain LTD

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Chembrain LTD

RecordFirmDate
The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients (NCT05063682)Chembrain LTD2020-05-15

Track Chembrain LTD automatically

Every clearance here is in the API, with alerts when new ones post.